Sandu Pharmaceuticals Ltd vs Sanofi India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Sandu Pharmaceuticals Ltd is ₹ 44 as of 30 Apr 15:30 . The p/e ratio of Sandu Pharmaceuticals Ltd changed from 33.3 to 30.4 over 3 quarters. This represents a CAGR of -11.44% The p/e ratio of Sanofi India Ltd changed from 30.8 to 0 over 5 quarters. This represents a CAGR of -100.00% The market cap of Sandu Pharmaceuticals Ltd changed from ₹ 50.43 crore to ₹ 47.33 crore over 3 quarters. This represents a CAGR of -8.11% The market cap of Sanofi India Ltd changed from ₹ 18578 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of -100.00% The revenue of Sandu Pharmaceuticals Ltd for the Mar '25 is ₹ 14.14 crore as compare to the Dec '24 revenue of ₹ 18.4 crore. This represent the decline of -23.15% The revenue of Sanofi India Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 526.3 crore. This represent the decline of -100% The ebitda of Sandu Pharmaceuticals Ltd for the Mar '25 is ₹ 0.52 crore as compare to the Dec '24 ebitda of ₹ 1.02 crore. This represent the decline of -49.02% The ebitda of Sanofi India Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 122 crore. This represent the decline of -100% The net profit of Sandu Pharmaceuticals Ltd changed from ₹ 0.17 crore to ₹ 0.33 crore over 4 quarters. This represents a CAGR of 94.12% The net profit of Sanofi India Ltd changed from ₹ 136.6 crore to ₹ 0 crore over 4 quarters. This represents a CAGR of -100.00% The dividend payout of Sandu Pharmaceuticals Ltd changed from 36.33 % to 49.86 % over 5 quarters. This represents a CAGR of 28.82% The dividend payout of Sanofi India Ltd changed from 119.34 % to 0 % over 10 quarters. This represents a CAGR of -100.00% .

About Sandu Pharmaceuticals Ltd

Sandu Pharmaceuticals Ltd (SPL) was established in 1985.
The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name SANDU. SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.'94, to part-finance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations.
This plant employs the latest material handling systems and other modern machinery and has the most hygienic production facilities to attain the highest possible quality standards.
Ayurvedic products have a very good market in India and abroad due to their minimal side effects. The company commenced commercial production of Ayurvedic Medicines & Formulations, at the Goa plant in 1996-97.
Thereafter, it commenced production of manufacturing Unit II in Goa from May, 2002.

About Sanofi India Ltd

Sanofi India Limited, was initially incorporated as 'Aventis Pharma Limited' in May, 1956.
The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.
The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.
The Company is primarily engaged in the business of manufacturing and trading of drugs s and pharmaceuticals.
It has its own manufacturing facility at Goa.

FAQs for the comparison of Sandu Pharmaceuticals Ltd and Sanofi India Ltd

Which company has a larger market capitalization, Sandu Pharmaceuticals Ltd or Sanofi India Ltd?

Market cap of Sandu Pharmaceuticals Ltd is 42 Cr while Market cap of Sanofi India Ltd is 8,111 Cr

What are the key factors driving the stock performance of Sandu Pharmaceuticals Ltd and Sanofi India Ltd?

The stock performance of Sandu Pharmaceuticals Ltd and Sanofi India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sandu Pharmaceuticals Ltd and Sanofi India Ltd?

As of May 3, 2026, the Sandu Pharmaceuticals Ltd stock price is INR ₹44.0. On the other hand, Sanofi India Ltd stock price is INR ₹3522.25.

How do dividend payouts of Sandu Pharmaceuticals Ltd and Sanofi India Ltd compare?

To compare the dividend payouts of Sandu Pharmaceuticals Ltd and Sanofi India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.